Title | Description |
|---|---|
| Trial ID | KF5503/52 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | Tapentadol in chronic malignant tumor related pain |
| Indication | Tumor-related pain, Chronic pain |
| UTN | |
| CTG ID | NCT01264887 |
| CTIS ID (former EudraCT) | 2009-013291-46 |
| Trial status | Completed |
| FPI | March 3, 2011 |
| LPO | May 8, 2014 |
| Countries | Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Spain, Austria, Croatia, Slovakia, United Kingdom, Netherlands |
| Gender | All |
| Age | 18 and 80 years |
| Results | Yes |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.